Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

BACKGROUND: COVID-19 is a multisystem disease that presents acute and persistent symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to consequences from organ or tissue injury caused by SARS-CoV-2, associated clotting or inflammatory processes during acute COVID-19. Various strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebelatto, Carmen Lúcia Kuniyoshi, Senegaglia, Alexandra Cristina, Franck, Claudio Luciano, Daga, Debora Regina, Shigunov, Patrícia, Stimamiglio, Marco Augusto, Marsaro, Daniela Boscaro, Schaidt, Bruna, Micosky, Andressa, de Azambuja, Ana Paula, Leitão, Cleverson Alex, Petterle, Ricardo Rasmussen, Jamur, Valderez Ravaglio, Vaz, Isadora May, Mallmann, Antônio Paulo, Carraro Junior, Hipólito, Ditzel, Eduardo, Brofman, Paulo Roberto Slud, Correa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935270/
https://www.ncbi.nlm.nih.gov/pubmed/35313959
http://dx.doi.org/10.1186/s13287-022-02796-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935270/
https://www.ncbi.nlm.nih.gov/pubmed/35313959
http://dx.doi.org/10.1186/s13287-022-02796-1

Ejemplares similares